Material World: AMSilk Secures Over $60M to Scale, Sealwool’s Biomimetic Twist

“AMSilk’s transition to full-scale production signals strong commercial validation,” said Daniel Kolb, investment manager at Athos, a Munich-based single-family office. “The company’s ability to manufacture biofabricated materials at multi-ton volumes confirms its industrial viability and readiness to meet growing market demand.”To manufacture AMSilk’s proprietary silk-based protein materials, specifically configured and dedicated production facilities have been installed at the company’s key industrial par ...